Fig. 5From: Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)Changes in collateral artery development on angiography 6 months following implantation of placenta-derived mesenchymal stem cells (P-MSC). A Collateral vessel formation was increased at 6 months after P-MSC administration. B The degree of collateral vessel formation was ranked as 0, + 1, + 2, and + 3 according to the number of collaterals (P value = 0.0625)Back to article page